As several studies recently revealed mechanical regulations of receptor tyrosine kinase (RTK), including EGFR signaling in cancers [6,7,45,46], these together imply roles of EGFR dynamics in advanced malignancy in prostate cancer and their potential as biophysical markers for this disease. The gene discussed is NTRK1; the disease is prostate carcinoma.